165 related articles for article (PubMed ID: 11501716)
1. Biotechnology at Yale.
Shiao S
Yale J Biol Med; 2001; 74(3):197-9. PubMed ID: 11501716
[No Abstract] [Full Text] [Related]
2. Value creation and sharing among universities, biotechnology and pharma.
Edwards MG; Murray F; Yu R
Nat Biotechnol; 2003 Jun; 21(6):618-24. PubMed ID: 12776145
[No Abstract] [Full Text] [Related]
3. Fresh horizons South Korea.
Cyranoski D
Nature; 2002 Dec; 420(6916):4-5. PubMed ID: 12478244
[No Abstract] [Full Text] [Related]
4. Cementing links between industry and the university.
Jennings R
Nat Biotechnol; 1998 May; 16 Suppl():35-6. PubMed ID: 9591263
[No Abstract] [Full Text] [Related]
5. Universities could gain from backing biotech.
Kamb A
Nature; 2003 Mar; 422(6928):113. PubMed ID: 12634753
[No Abstract] [Full Text] [Related]
6. Industry and the university.
Haber E
Nat Biotechnol; 1996 Apr; 14(4):441-2. PubMed ID: 9630917
[No Abstract] [Full Text] [Related]
7. Technology managers do their bit for world health.
Stevens AJ
Nature; 2005 Jun; 435(7042):561. PubMed ID: 15931194
[No Abstract] [Full Text] [Related]
8. University-industry collaboration. Last of the big-time spenders?
Lawler A
Science; 2003 Jan; 299(5605):330-3. PubMed ID: 12531991
[No Abstract] [Full Text] [Related]
9. Biotech patents-business as usual?
Lawrence S
Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
[No Abstract] [Full Text] [Related]
10. Golden opportunities.
Smaglik P
Nature; 2005 Jul; 436(7047):144-7. PubMed ID: 16007735
[No Abstract] [Full Text] [Related]
11. Upending the zeitgeist.
Nature; 2006 Jun; 441(7093):572-3. PubMed ID: 16738631
[No Abstract] [Full Text] [Related]
12. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
Westerlund L
Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
[No Abstract] [Full Text] [Related]
13. Finnish biotechnology--built on solid foundations.
Lähteenmäki R
Nature; 2002 Dec; 420(6916 Suppl):A34-5, A37, A39. PubMed ID: 12501125
[No Abstract] [Full Text] [Related]
14. [Change the world through business partnering - commercialization of biotechnology and open-innovation].
Tsukamoto Y
Nihon Yakurigaku Zasshi; 2013 May; 141(5):268-74. PubMed ID: 23665558
[No Abstract] [Full Text] [Related]
15. Research interactions between industry and academia: a corporate perspective.
Citron P
Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
[No Abstract] [Full Text] [Related]
16. Ontario.
Hoag H
Nature; 2005 Mar; 434(7033):676-7. PubMed ID: 15800632
[No Abstract] [Full Text] [Related]
17. Biotechnology. French drug industry initiative.
Anderson C
Nature; 1991 Oct; 353(6344):487. PubMed ID: 1922346
[No Abstract] [Full Text] [Related]
18. Biotech round the world: focus on Canada.
Biotechnol J; 2008 Jul; 3(7):848-51. PubMed ID: 18624341
[No Abstract] [Full Text] [Related]
19. Gold in the ivory tower: equity rewards of outlicensing.
Edwards M; Murray F; Yu R
Nat Biotechnol; 2006 May; 24(5):509-15. PubMed ID: 16680129
[TBL] [Abstract][Full Text] [Related]
20. Basic drug research in universities and industry.
Black J
Br J Clin Pharmacol; 1986; 22 Suppl 1(Suppl 1):5S-7S. PubMed ID: 3567032
[No Abstract] [Full Text] [Related]
[Next] [New Search]
